![PLA1A expression as a diagnostic marker of BRAF-mutant metastasis in melanoma cancer | Scientific Reports PLA1A expression as a diagnostic marker of BRAF-mutant metastasis in melanoma cancer | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-021-85595-7/MediaObjects/41598_2021_85595_Fig3_HTML.png)
PLA1A expression as a diagnostic marker of BRAF-mutant metastasis in melanoma cancer | Scientific Reports
![Melanoma Persister Cells Are Tolerant to BRAF/MEK Inhibitors via ACOX1-Mediated Fatty Acid Oxidation - ScienceDirect Melanoma Persister Cells Are Tolerant to BRAF/MEK Inhibitors via ACOX1-Mediated Fatty Acid Oxidation - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2211124720314108-fx1.jpg)
Melanoma Persister Cells Are Tolerant to BRAF/MEK Inhibitors via ACOX1-Mediated Fatty Acid Oxidation - ScienceDirect
![Frontiers | Cutaneous Melanoma Classification: The Importance of High-Throughput Genomic Technologies Frontiers | Cutaneous Melanoma Classification: The Importance of High-Throughput Genomic Technologies](https://www.frontiersin.org/files/Articles/635488/fonc-11-635488-HTML/image_m/fonc-11-635488-g003.jpg)
Frontiers | Cutaneous Melanoma Classification: The Importance of High-Throughput Genomic Technologies
![Temporal course of serum tumor marker levels and radiologic tumor mass... | Download Scientific Diagram Temporal course of serum tumor marker levels and radiologic tumor mass... | Download Scientific Diagram](https://www.researchgate.net/publication/319625078/figure/fig3/AS:963516810924046@1606731717447/Temporal-course-of-serum-tumor-marker-levels-and-radiologic-tumor-mass-measuring-in-a.gif)
Temporal course of serum tumor marker levels and radiologic tumor mass... | Download Scientific Diagram
![Cancers | Free Full-Text | BRAF and MEK Targeted Therapies in Pediatric Central Nervous System Tumors | HTML Cancers | Free Full-Text | BRAF and MEK Targeted Therapies in Pediatric Central Nervous System Tumors | HTML](https://www.mdpi.com/cancers/cancers-14-04264/article_deploy/html/images/cancers-14-04264-g001.png)
Cancers | Free Full-Text | BRAF and MEK Targeted Therapies in Pediatric Central Nervous System Tumors | HTML
![Objective assessment of tumor infiltrating lymphocytes as a prognostic marker in melanoma using machine learning algorithms - eBioMedicine Objective assessment of tumor infiltrating lymphocytes as a prognostic marker in melanoma using machine learning algorithms - eBioMedicine](https://www.thelancet.com/cms/attachment/b82fbc79-1c37-4496-ba83-aaa395efa9c3/gr1_lrg.jpg)
Objective assessment of tumor infiltrating lymphocytes as a prognostic marker in melanoma using machine learning algorithms - eBioMedicine
![BRAFV600E mutation and expression of proangiogenic molecular markers in papillary thyroid carcinomas in: European Journal of Endocrinology Volume 165 Issue 3 (2011) BRAFV600E mutation and expression of proangiogenic molecular markers in papillary thyroid carcinomas in: European Journal of Endocrinology Volume 165 Issue 3 (2011)](https://eje.bioscientifica.com/view/journals/eje/165/3/images/large/455fig5.jpeg)
BRAFV600E mutation and expression of proangiogenic molecular markers in papillary thyroid carcinomas in: European Journal of Endocrinology Volume 165 Issue 3 (2011)
![Time to re‐consider the meaning of BRAF V600E mutation in papillary thyroid carcinoma - Gandolfi - 2015 - International Journal of Cancer - Wiley Online Library Time to re‐consider the meaning of BRAF V600E mutation in papillary thyroid carcinoma - Gandolfi - 2015 - International Journal of Cancer - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/f4b801ac-975c-484f-8067-d8837c6f4edb/ijc28976-fig-0003-m.jpg)
Time to re‐consider the meaning of BRAF V600E mutation in papillary thyroid carcinoma - Gandolfi - 2015 - International Journal of Cancer - Wiley Online Library
![Time to re‐consider the meaning of BRAF V600E mutation in papillary thyroid carcinoma - Gandolfi - 2015 - International Journal of Cancer - Wiley Online Library Time to re‐consider the meaning of BRAF V600E mutation in papillary thyroid carcinoma - Gandolfi - 2015 - International Journal of Cancer - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/a3f708bb-e384-4730-a0a6-0d1f16043eb1/ijc28976-fig-0002-m.jpg)
Time to re‐consider the meaning of BRAF V600E mutation in papillary thyroid carcinoma - Gandolfi - 2015 - International Journal of Cancer - Wiley Online Library
![Clinical Impact of Circulating Tumor RAS and BRAF Mutation Dynamics in Patients With Metastatic Colorectal Cancer Treated With First-Line Chemotherapy Plus Anti–Epidermal Growth Factor Receptor Therapy | JCO Precision Oncology Clinical Impact of Circulating Tumor RAS and BRAF Mutation Dynamics in Patients With Metastatic Colorectal Cancer Treated With First-Line Chemotherapy Plus Anti–Epidermal Growth Factor Receptor Therapy | JCO Precision Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/po/2019/po.2019.3/po.18.00289/20190522/images/large/po.18.00289t1.jpeg)
Clinical Impact of Circulating Tumor RAS and BRAF Mutation Dynamics in Patients With Metastatic Colorectal Cancer Treated With First-Line Chemotherapy Plus Anti–Epidermal Growth Factor Receptor Therapy | JCO Precision Oncology
![Frontiers | Non-invasive Technology Advances in Cancer—A Review of the Advances in the Liquid Biopsy for Endometrial and Ovarian Cancers Frontiers | Non-invasive Technology Advances in Cancer—A Review of the Advances in the Liquid Biopsy for Endometrial and Ovarian Cancers](https://www.frontiersin.org/files/Articles/573010/fdgth-02-573010-HTML/image_m/fdgth-02-573010-g001.jpg)
Frontiers | Non-invasive Technology Advances in Cancer—A Review of the Advances in the Liquid Biopsy for Endometrial and Ovarian Cancers
![High Concordance and Negative Prognostic Impact of RAS/BRAF/PIK3CA Mutations in Multiple Resected Colorectal Liver Metastases - Clinical Colorectal Cancer High Concordance and Negative Prognostic Impact of RAS/BRAF/PIK3CA Mutations in Multiple Resected Colorectal Liver Metastases - Clinical Colorectal Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/1567ee78-6a61-46b6-87a3-54507dea6864/gr3_lrg.jpg)
High Concordance and Negative Prognostic Impact of RAS/BRAF/PIK3CA Mutations in Multiple Resected Colorectal Liver Metastases - Clinical Colorectal Cancer
![Clinical Impact of Circulating Tumor RAS and BRAF Mutation Dynamics in Patients With Metastatic Colorectal Cancer Treated With First-Line Chemotherapy Plus Anti–Epidermal Growth Factor Receptor Therapy | JCO Precision Oncology Clinical Impact of Circulating Tumor RAS and BRAF Mutation Dynamics in Patients With Metastatic Colorectal Cancer Treated With First-Line Chemotherapy Plus Anti–Epidermal Growth Factor Receptor Therapy | JCO Precision Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/po/2019/po.2019.3/po.18.00289/20190522/images/large/po.18.00289ta2.jpeg)
Clinical Impact of Circulating Tumor RAS and BRAF Mutation Dynamics in Patients With Metastatic Colorectal Cancer Treated With First-Line Chemotherapy Plus Anti–Epidermal Growth Factor Receptor Therapy | JCO Precision Oncology
![Clinical utility of circulating DNA analysis for rapid detection of actionable mutations to select metastatic colorectal patients for anti-EGFR treatment - Annals of Oncology Clinical utility of circulating DNA analysis for rapid detection of actionable mutations to select metastatic colorectal patients for anti-EGFR treatment - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/44aeee08-90e2-44d2-be98-fdcd6380cabf/gr1_lrg.jpg)
Clinical utility of circulating DNA analysis for rapid detection of actionable mutations to select metastatic colorectal patients for anti-EGFR treatment - Annals of Oncology
![Lack of predictive tools for conventional and targeted cancer therapy: Barriers to biomarker development and clinical translation - ScienceDirect Lack of predictive tools for conventional and targeted cancer therapy: Barriers to biomarker development and clinical translation - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0169409X21002465-gr1.jpg)
Lack of predictive tools for conventional and targeted cancer therapy: Barriers to biomarker development and clinical translation - ScienceDirect
![Histologic variants and rates of BRAF mutation. The percentage given... | Download Scientific Diagram Histologic variants and rates of BRAF mutation. The percentage given... | Download Scientific Diagram](https://www.researchgate.net/publication/275711819/figure/fig1/AS:1086804396650497@1636125768160/Histologic-variants-and-rates-of-BRAF-mutation-The-percentage-given-after-the-number-of.jpg)
Histologic variants and rates of BRAF mutation. The percentage given... | Download Scientific Diagram
![Detection of BRAF mutation in Chinese tumor patients using a highly sensitive antibody immunohistochemistry assay | Scientific Reports Detection of BRAF mutation in Chinese tumor patients using a highly sensitive antibody immunohistochemistry assay | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsrep09211/MediaObjects/41598_2015_Article_BFsrep09211_Fig1_HTML.jpg)
Detection of BRAF mutation in Chinese tumor patients using a highly sensitive antibody immunohistochemistry assay | Scientific Reports
![Discovery of a new molecule inducing melanoma cell death: dual AMPK/MELK targeting for novel melanoma therapies | Cell Death & Disease Discovery of a new molecule inducing melanoma cell death: dual AMPK/MELK targeting for novel melanoma therapies | Cell Death & Disease](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41419-020-03344-6/MediaObjects/41419_2020_3344_Fig1_HTML.png)